Nucleophilic Addition of the Hydroxyl Group to 60Fullerene
1
1
Pyrrolidino[3,4:1,2][60]fullerene (3b). H NMR (CDCl3/CS2,
Compound 8. H NMR (CDCl3, 298 K, 300 MHz) δ 2.75 (s,
298 K, 500 MHz) δ 2.98 (s, 3H, CH3-N), 3.68 (s, 3H, OCH3),
3.76 (s, 3H, OCH3), 4.30 (d, 1H, J ) 9.6 Hz, CH2-N), 5.07 (d,
1H, J ) 9.6 Hz, CH2-N), 5.70 (s, 1H, CH-N), 5.99 (d, 1H, J )
2.3 Hz, H-Ar), 6.04 (d, 1H, J ) 2.3 Hz, H-Ar), 11.59 (s, 1H,
OH); 13C NMR (CDCl3/CS2, 298 K, 125 MHz) δ 41.0, 55.5, 55.7,
69.2, 69.8, 76.8, 91.4, 94.8, 101.7, 128.7, 134.6, 136.2, 136.7, 137.3,
138.2, 138.4, 139.2, 139.9, 140.0, 140.6, 140.7, 142.0, 142.1,
142.12, 142.4, 142.5, 142.59, 142.6, 142.66, 142.7, 143.0, 143.09,
143.1, 143.4, 144.79, 144.8, 144.9, 145.1, 145.5, 145.57, 145.6,
145.65, 145.7, 145.8, 145.9, 146.0, 146.2, 146.3, 146.4, 146.5,
146.57, 146.6, 146.67, 146.7, 146.74, 146.8, 147.1, 147.7, 147.8,
153.2, 153.4, 155.1, 156.1, 159.6, 159.65, 162.1; MS (ESI) m/z
929 [M+]
3H, CH3), 3.00 (s, 3H, CH3-N), 4.72 (AB system, 2H, CH2N),
4.75 (s, 1H, OH), 6.16 (dd, 1H, J ) 8.0, 1.1 Hz, H-Ar), 6.45 (dd,
1H, J ) 8.0, 1.1 Hz, H-Ar), 6.99 (t, 1H, J ) 8.0 Hz, H-Ar),
13.92 (s, 1H, OH); 13C NMR (CDCl3/CS2, 298 K, 75 MHz) δ 30.4,
35.6, 63.9, 68.0, 80.1, 80.7, 108.0, 111.7, 112.8, 128.7, 130.4, 135.6,
136.5, 137.2, 139.1, 139.7, 140.6, 140.7, 141.9, 142.0, 142.07,
142.1, 142.2, 142.4, 142.47, 142.5, 142.7, 142.77, 142.8, 142.81,
143.0, 143.08, 143.1, 143.4, 143.5, 143.6, 144.8, 145.0, 145.1,
145.4, 145.5, 145.6, 145.7, 145.76, 145.8, 145.9, 146.1, 146.2,
146.3, 146.4, 146.5, 146.56, 146.6, 146.62, 146.7, 146.8, 146.83,
147.8, 147.9, 148.1, 153.7, 154.3, 154.4, 155.8, 156.3, 160.9; FTIR
(KBr, cm-1) 526.50, 574.57, 1151.88, 1452.16; MS (ESI) m/z 898
[M+].
Pyrrolidino[3,4:1,2][60]fullerene (6). 1H NMR (CDCl3, 298 K,
300 MHz) δ 2.45 (s, 3H, CH3), 2.97 (s, 3H, CH3-N), 4.74 (d, 1H,
J ) 10.1 Hz, CH2-N), 4.97 (d, 1H, J ) 10.1 Hz, CH2-N),
6.90-6.85 (m, 2H, H-Ar), 7.20 (bs, 1H, H-Ar), 7.52 (dd, 1H, J
) 8.2, 1.5 Hz, H-Ar), 13.13 (s, 1H, OH); 13C NMR (CDCl3, 298
K, 75 MHz) δ 18.1, 35.4, 65.0, 68.0, 79.1, 80.9, 118.3, 119.8, 125.0,
128.1, 128.5, 130.6, 130.9, 132.96, 136.4, 136.5, 136.7, 136.9,
139.3, 140.2, 140.5, 140.6, 141.6, 141.8, 141.9, 142.0, 142.4, 142.5,
142.57, 142.6, 142.7, 142.8, 143.0, 143.1, 143.5, 144.8, 145.0,
145.07, 145.5, 145.6, 145.69, 145.7, 145.74, 145.8, 146.0, 146.2,
146.27, 146.3, 146.4, 146.5, 146.57, 146.6, 146.68, 146.7, 146.8,
Compound 9. H NMR (CDCl3, 298 K, 300 MHz) δ 2.18 (s,
1
3H, CH3), 3.54 (s, 3H, CH3), 4.76 (d, 1H, J ) 12.7 Hz, CH2N),
5.00 (d, 1H, J ) 12.7 Hz, CH2-N), 6.29 (s, 1H, H-C60), 6.85 (dd,
1H, J ) 7.9, 1.1 Hz, H-Ar), 7.03 (dd, 1H, J ) 7.9, 1.1 Hz, H-Ar),
7.39 (t, 1H, J ) 8.0 Hz, H-Ar), 13.23 (s, 1H, OH); 13C NMR
(CDCl3/CS2, 298 K, 75 MHz) δ 36.5, 57.3, 66.2, 71.3, 75.4, 79.4,
92.4, 111.2, 113.7, 117.7, 130.0, 134.4, 135.5, 135.7, 136.2, 137.6,
140.8, 140.9, 141.6, 142.3, 142.46, 142.5, 142.6, 142.7, 142.8,
143.0, 143.2, 143.4, 143.6, 143.8, 143.9, 144.0, 144.04, 144.2,
144.3, 144.4, 144.5, 144.6, 144.7, 144.9, 145.1, 145.2, 145.3, 145.9,
146.1, 146.3, 146.5, 146.6, 146.9, 147.0, 147.05, 147.3, 147.9,
148.2, 148.7, 149.0, 149.1, 149.2, 150.1, 152.8, 154.0, 157.9; FTIR
(KBr, cm-1) 526.90, 575.17, 1197.22, 1462.20; MS (ESI) m/z 898
[M+].
146.9, 147.8, 153.0, 153.3, 153.9, 156.2, 158.5; FTIR (KBr, cm-1
)
526.58, 575.56, 1155.64, 1462.13; MS (MALDI TOF) 883 [M+].
1
Pyrrolidino[3,4:1,2][60]fullerene (11). H NMR (CDCl3, 298
K, 300 MHz) δ 2.99 (s, 3H, CH3), 4.35 (d, 1H, J ) 9.9 Hz,
CH2-N), 5.02 (s, 1H, OH), 5.09 (d, 1H, J ) 9.9 Hz, CH2-N),
5.81 (s, 1H, CH-N), 6.32 (d, 1H, J ) 8.1 Hz, H-Ar), 6.51 (d, 1H,
J ) 8.1 Hz, H-Ar), 7.07 (t, 1H, J ) 8.1 Hz, H-Ar), 11.77 (s, 1H,
OH); 13C NMR (CDCl3, 298 K, 75 MHz) δ 39.6, 67.9, 68.3, 68.6,
75.3, 105.4, 106.5, 109.5, 127.5, 128.5, 129.4, 133.7, 134.8, 135.4,
135.8, 136.0, 138.6, 138.7, 139.2, 139.3, 140.6, 140.66, 140.7,
140.8, 141.0, 141.1, 141.15, 141.18, 141.2, 141.3, 141.4, 141.6,
141.7, 141.75, 142.0, 142.1, 143.3, 143.4, 143.5, 143.6, 143.7,
144.1, 144.2, 144.25, 144.3, 144.33, 144.4, 144.5, 144.7, 144.8,
144.9, 145.0, 145.08, 145.1, 145.2, 145.25, 145.28, 145.3, 145.4,
145.7, 145.8, 146.3, 146.4, 151.4, 152.0, 153.6, 154.3, 154.4, 157.9;
FTIR (KBr, cm-1) 529.08, 1182.63, 1460. 64.
Synthesis of Pyrrolidino[3,4:1,2][60]fullerenes 8 and 9. To a
solution of 0.50 mmol (360 mg) of C60 in chlorobenzene (80 mL)
were added 0.75 mmol (114 mg) of 2,6-dihydroxyphenyl methyl
ketone (7) and 2.0 mmol (178 mg) of sarcosine. The mixture was
refluxed overnight, and after cooling to room temperature, the
solvent was removed in vacuo. The crude product was purified by
flash chromatography over silica gel, using toluene/ethyl acetate
9:1 to obtain compound 8 in 12% yield and compound 9 in 31%
yield.
Acknowledgment. This work was supported by the MEC of
Spain (project CT2005-02609/BQU, project CTQ2008-03077/
BQU and Consolider-Ingenio 2010C-07-25200), the CAM
(project P-PPQ-000225-0505) and the Catalan Departament
d’Universitats, Recerca i Societat de la Informacio´ (DURSI) of
the Generalitat de Catalunya project 2005SGR-00238. S.F.
thanks the MEC for a Ramo´n y Cajal contract, and S.O. thanks
the MEC for Doctoral Fellowship AP2005-2992. M.I. thanks
the European Science Foundation for Predoctoral contract
(SOHYD 05-SONS-FP-021).
Supporting Information Available: General procedure for
the synthesis of fulleropyrrolidines 3a, 3b, 6, and 11. 1H NMR,
13C NMR, and MS spectra of all compounds. HPLC of
compounds 8 and 9. CV voltammogram of compound 6 and
table of reduction potentials. Xyz optimized Cartesians coor-
dinates and total energies for all minima and transition states
located. Optimized structures and relative energies for the
different conformers of species 3a and 6. This material is
Compound 8 was further converted quantitatively to 9 by
refluxing in chlorobenzene for 4 h.
JO802152X
J. Org. Chem. Vol. 74, No. 4, 2009 1487